Now showing items 1-1 of 1

    • High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4 

      Mariño, Zoe; Pascasio-Acevedo, Juan M.; Gallego, Adolfo; Diago, Moisés; Baliellas, Carme; Morillas, Rosa; Prieto, Martín; Moreno, José M.; Sánchez-Antolín, Gloria; Vergara, Mercedes; Forné, Monserrat; Fernández, Inmaculada; Castro-Iglesias, Ángeles; Pascual, Sonia; Gómez, Alexandra; Castells, Lluis; Montero, José L.; Crespo, Javier; Calleja, José L.; García-Samaniego, Javier; Carrión, José A.; Arencibia, Ana C.; Blasco, Alejandro; López-Núñez, Carmen; Sánchez-Ruano, Juan J.; Gea-Rodríguez, Francisco; Giráldez, Álvaro; Cabezas, Joaquín; Hontangas, Vanessa; Torras, Xavier; Castellote, José; Romero-Gómez, Manuel; Turnes, Juan; Artaza, Tomás de; Narváez, Isidro; Cuevas-Mons, Valentín; Forns, Xavier (Wiley, 2017-05-08)
      [Abstract] Background and Aims. Hepatitis C (HCV) therapy with Sofosbuvir (SOF)/Simeprevir (SMV) in clinical trials and real‐world clinical practice, showed high rates of sustained virological response (SVR) in non‐cirrhotic ...